Intrathecal Agent Clinical Trials

For a Newly Diagnosed Patient

There are currently no listings. Please check back.

For a Patient with Recurrent or Relapsed Disease

PBTC 019: Phase I and Pharmacokinetic Optimal Dosing of Intrathecal Topotecan (New Agent)



Page modified on July 12, 2021